| Removal of the pro-domain does not affect the conformation of the procaspase-3 dimer C Pop, YR Chen, B Smith, K Bose, B Bobay, A Tripathy, S Franzen, ... Biochemistry 40 (47), 14224-14235, 2001 | 86 | 2001 |
| The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases N Singh, RR Kuppili, K Bose Archives of biochemistry and biophysics 516 (2), 85-96, 2011 | 85 | 2011 |
| An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3 K Bose, C Pop, B Feeney, AC Clark Biochemistry 42 (42), 12298-12310, 2003 | 79 | 2003 |
| Dimeric procaspase-3 unfolds via a four-state equilibrium process K Bose, AC Clark Biochemistry 40 (47), 14236-14242, 2001 | 73 | 2001 |
| An efficient method for FITC labelling of proteins using tandem affinity purification LK Chaganti, N Venkatakrishnan, K Bose Bioscience reports 38 (6), BSR20181764, 2018 | 54 | 2018 |
| Dual regulatory switch confers tighter control on HtrA2 proteolytic activity N Singh, A D'Souza, A Cholleti, GM Sastry, K Bose The FEBS journal 281 (10), 2456-2470, 2014 | 41 | 2014 |
| pH effects on the stability and dimerization of procaspase‐3 K Bose, AC Clark Protein Science 14 (1), 24-36, 2005 | 39 | 2005 |
| Allosteric regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket PR Bejugam, RR Kuppili, N Singh, N Gadewal, LK Chaganti, GM Sastry, ... PloS one 8 (2), e55416, 2013 | 38 | 2013 |
| Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks NV Ivanisenko, K Seyrek, LK Hillert-Richter, C König, J Espe, K Bose, ... Trends in Cancer 8 (3), 190-209, 2022 | 37 | 2022 |
| Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2 LK Chaganti, RR Kuppili, K Bose The FASEB Journal 27 (8), 3054-3066, 2013 | 36 | 2013 |
| Molecular basis of death effector domain chain assembly and its role in caspase‐8 activation N Singh, A Hassan, K Bose The FASEB Journal 30 (1), 186-200, 2016 | 26 | 2016 |
| Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics S Bhattacharya, D Reddy, V Jani, N Gadewal, S Shah, R Reddy, K Bose, ... Epigenetics & chromatin 10, 1-19, 2017 | 19 | 2017 |
| Proteases in apoptosis: pathways, protocols and translational advances K Bose Springer, 2015 | 17 | 2015 |
| Disorder and structure in the Rab11 binding domain of Rab11 family interacting protein 2 J Wei, Y Liu, K Bose, GD Henry, JD Baleja Biochemistry 48 (3), 549-557, 2009 | 15 | 2009 |
| Discerning the mechanism of action of HtrA4: a serine protease implicated in the cell death pathway R Kummari, S Dutta, LK Chaganti, K Bose Biochemical Journal 476 (10), 1445-1463, 2019 | 12 | 2019 |
| Structural basis of inactivation of human counterpart of mouse motor neuron degeneration 2 mutant in serine protease HtrA2 AR Wagh, K Bose Bioscience reports 38 (5), BSR20181072, 2018 | 12 | 2018 |
| Insights into the mechanism of human papillomavirus E2-induced procaspase-8 activation and cell death N Singh, S Senapati, K Bose Scientific reports 6 (1), 21408, 2016 | 12 | 2016 |
| Apoptosis: pathways, molecules and beyond N Singh, K Bose Proteases in Apoptosis: Pathways, Protocols and Translational Advances, 1-30, 2015 | 11 | 2015 |
| Remodelling structure-based drug design using machine learning S Dutta, K Bose Emerging Topics in Life Sciences 5 (1), 13-27, 2021 | 10 | 2021 |
| Structural modeling and role of HAX-1 as a positive allosteric modulator of human serine protease HtrA2 LK Chaganti, S Dutta, RR Kuppili, M Mandal, K Bose Biochemical Journal 476 (20), 2965-2980, 2019 | 9 | 2019 |
